指南与共识慢阻肺

优化比利时慢阻肺照护:心肺风险管理多学科专家共识

Optimizing COPD Care in Belgium: A Multidisciplinary Expert Consensus on Cardiopulmonary Risk Management
RSS 订阅 · 指南共识 · 慢阻肺 · 2026-04-06

比利时多学科专家组通过结构化研讨会和迭代共识制定慢阻肺心肺风险管理路径,聚焦至少一次中重度急性加重的高危患者。共识提出整合式阶梯框架,涵盖基层识别、住院标准化检查和出院规划,结合嗜酸性粒细胞指导吸入治疗与心血管治疗,并明确转诊阈值。

要点

  • 慢阻肺患者中心肺风险常被低估,需在急性加重后系统识别。
  • 共识提出覆盖基层、住院和出院随访的整合式阶梯管理框架。
  • 药物策略结合嗜酸性粒细胞指导吸入治疗与指南导向心血管治疗。

核心结论

  • 该共识通过整合碎片化建议形成可操作算法,将呼吸与心脏照护结合,可能减少急性加重并改善心血管结局。

研究设计与样本

  • 比利时多学科工作组(全科医生、呼吸科医生、心内科医生、药师、流行病学家)通过结构化研讨会和迭代共识制定务实、循证照护路径。

主要发现

  • 共识推荐聚焦至少一次中重度急性加重且心肺风险增高的慢阻肺患者。
  • 核心要素包括基层系统性心肺风险识别、住院标准化诊断检查和 multidisciplinary 出院规划。
  • 药物策略结合嗜酸性粒细胞指导吸入治疗与指南导向心血管治疗。
  • 非药物措施强化戒烟、疫苗接种、体力活动和肺康复。
  • 定义了基层、呼吸科和心内科之间的明确转诊阈值,并辅以患者教育和数字监测工具。

关键数值与推荐

  • 慢阻肺在比利时影响约800,000人,其中半数未确诊。

临床怎么用

  • 对至少一次中重度急性加重的慢阻肺患者,应在基层主动识别心肺风险并按阶梯框架管理。
  • 住院期间执行标准化诊断检查,出院时进行多学科规划并明确转诊阈值。
  • 药物治疗结合嗜酸性粒细胞指导的吸入治疗与指南导向心血管治疗,同时强化非药物措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Int J Chron Obstruct Pulmon Dis. 2026 Jan 13;21:578651. doi: 10.2147/COPD.S578651. eCollection 2026. ABSTRACT INTRODUCTION: Chronic obstructive pulmonary disease (COPD) represents a major health and economic challenge in Belgium, affecting approximately 800,000 individuals, half of whom remain undiagnosed. Beyond respiratory morbidity, COPD patients face substantial cardiopulmonary (CP) risk-encompassing severe exacerbations and cardiovascular (CV) events-that is often under-recognized and insufficiently addressed due to limited clinical awareness, fragmented care, and the absence of national guidance. METHODS: A multidisciplinary Belgian taskforce (general practitioners, pulmonologists, cardiologists, pharmacists, epidemiologists) convened through structured workshops and iterative consensus-building to develop a pragmatic, evidence-informed care pathway. The recommendations focus on COPD patients with at least one moderate or severe exacerbation, who are at heightened CP risk. RESULTS: This consensus introduces an integrated, stepwise framework that positions CP risk as a central component of COPD management after exacerbation and operationalizes it across primary care, hospitalization, and post-exacerbation follow-up. Core elements include systematic and proactive CP risk identification in primary care, standardized diagnostic workups during hospitalization, and multidisciplinary discharge planning. Pharmacological strategies combine eosinophil-guided inhaler therapy with guideline-directed CV treatment, while non-pharmacological measures reinforce smoking cessation, vaccination, physical activity, and pulmonary rehabilitation. Clear referral thresholds between primary care, pulmonology, and cardiology are defined, supported by patient education and digital monitoring tools. CONCLUSION: This Belgian consensus complements international guidelines by consolidating fragmented recommendations into coherent, actionable algorithms that bridge gaps in routine practice. Its contribution lies in translating emerging evidence into structured, real-world pathways that integrate respiratory and cardiac care. Adoption of this framework may help reduce exacerbations, improve CV outcomes, and support multidisciplinary COPD care in Belgium. PMID: 41939929 | PMC: PMC13047776 | DOI: 10.2147/COPD.S578651

来源:指南共识 · 慢阻肺,查看原文。版权归原作者所有。

引用

  1. 指南共识 · 慢阻肺:Optimizing COPD Care in Belgium: A Multidisciplinary Expert Consensus on Cardiopulmonary Risk Management

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。